Literature DB >> 7870675

Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization.

B L Chen1, T Arakawa, C F Morris, W C Kenney, C M Wells, C G Pitt.   

Abstract

Recombinant human keratinocyte growth factor (rhKGF) is prone to aggregation at elevated temperatures. Its aggregation pathway is proposed to proceed initially with a conformational change which perhaps results from repulsion between positively charged residues in clusters forming heparin binding sites. Unfolding of the protein leads to formation of large soluble aggregates. These soluble aggregates then form disulfide cross-linked precipitates. Finally these precipitates are converted to scrambled disulfides and/or non-disulfide cross-linked precipitates. Stabilizers such as heparin, sulfated polysaccharides, anionic polymers and citrate can greatly decrease the rate of aggregation of rhKGF at elevated temperatures. These molecules may all act by reducing charge repulsion on the protein thus stabilizing the native conformation. EDTA, on the other hand, is found to inhibit disulfide formation in aggregates and has only a moderate stabilizing effect on rhKGF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870675     DOI: 10.1023/a:1018905720139

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Spectroscopic determination of tryptophan and tyrosine in proteins.

Authors:  H Edelhoch
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development.

Authors:  B L Chen; T Arakawa; E Hsu; L O Narhi; T J Tressel; S L Chien
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

4.  Role of aggregated human growth hormone (hGH) in development of antibodies to hGH.

Authors:  W V Moore; P Leppert
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

5.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

6.  Effect of polyanions on the unfolding of acidic fibroblast growth factor.

Authors:  C J Burke; D B Volkin; H Mach; C R Middaugh
Journal:  Biochemistry       Date:  1993-06-29       Impact factor: 3.162

7.  Heparin protects basic and acidic FGF from inactivation.

Authors:  D Gospodarowicz; J Cheng
Journal:  J Cell Physiol       Date:  1986-09       Impact factor: 6.384

8.  Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children.

Authors:  C Rougeot; P Marchand; F Dray; F Girard; J C Job; M Pierson; C Ponte; P Rochiccioli; R Rappaport
Journal:  Horm Res       Date:  1991

9.  Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro.

Authors:  T K Rosengart; W V Johnson; R Friesel; R Clark; T Maciag
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

10.  Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants.

Authors:  D Ron; D P Bottaro; P W Finch; D Morris; J S Rubin; S A Aaronson
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  12 in total

Review 1.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

2.  Aggregation of recombinant human interferon alpha 2b in solution: technical note.

Authors:  Llamil Ruiz; Kethia Aroche; Nuria Reyes
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

3.  Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide.

Authors:  D K Clodfelter; A H Pekar; D M Rebhun; K A Destrampe; H A Havel; S R Myers; M L Brader
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

4.  Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.

Authors:  B S Chang; R M Beauvais; T Arakawa; L O Narhi; A Dong; D I Aparisio; J F Carpenter
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

Review 5.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

6.  Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.

Authors:  A Singla; R Bansal; Varsha Joshi; Anurag S Rathore
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

7.  A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.

Authors:  Liang Zhang; Tejas Navaratna; Greg M Thurber
Journal:  Bioconjug Chem       Date:  2016-06-29       Impact factor: 4.774

8.  Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimetry.

Authors:  R L Remmele; N S Nightlinger; S Srinivasan; W R Gombotz
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

9.  A new strategy for enhancing the stability of lyophilized protein: the effect of the reconstitution medium on keratinocyte growth factor.

Authors:  M Z Zhang; J Wen; T Arakawa; S J Prestrelski
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

10.  Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats.

Authors:  R J Panos; P M Bak; W S Simonet; J S Rubin; L J Smith
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.